eCIO Inc’s AbbVie ABBV Stock Holding History

eCIO Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-693	Closed	-$158K	–	45
2025 Q4	$158K	Buy	+693	New	+$158K	0.07%	58
2025 Q2	–	Sell	-871	Closed	-$182K	–	74
2025 Q1	$182K	Buy	+871	New	+$169K	0.06%	116

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

eCIO Inc's ABBV Position: Q1 2026 in Review

eCIO Inc sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 693 shares — an estimated $158K sold.

eCIO Inc first reported a position in ABBV in Q1 2025 and held it in 2 quarters. The position peaked at $182K in Q1 2025. 4,097 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

eCIO Inc reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
eCIO Inc sold 693 AbbVie shares in Q1 2026, an estimated $158K.
eCIO Inc first reported a position in AbbVie in Q1 2025 and held it in 2 quarters.
eCIO Inc's AbbVie position peaked at $182K in Q1 2025.
4,097 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on eCIO Inc's 13F filing for Q1 2026, filed 14 Apr 2026.